Differential resistance in HIV-1 protease: the role of residue 50 in pathways for amprenavir/darunavir and atazanavir resistance

被引：0
|
作者：
Bandaranayake, R. M. [1 ]
Mittal, S. [1 ]
King, N. M. [1 ]
Prabu-Jeyabalan, M. [1 ,2 ]
Nalam, M. N. L. [1 ]
Schiffer, C. A. [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
[2] Commonwealth Med Coll, Scranton, PA USA
来源：
ANTIVIRAL THERAPY | 2010年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A14 / A14
页数：1
相关论文
共 50 条
  • [1] Structural and Thermodynamic Basis of Amprenavir/Darunavir and Atazanavir Resistance in HIV-1 Protease with Mutations at Residue 50
    Mittal, Seema
    Bandaranayake, Rajinthna M.
    King, Nancy M.
    Prabu-Jeyabalan, Moses
    Nalam, Madhavi N. L.
    Nalivaika, Ellen A.
    Yilmaz, Nese Kurt
    Schiffer, Celia A.
    [J]. JOURNAL OF VIROLOGY, 2013, 87 (08) : 4176 - 4184
  • [2] The higher barrier of darunavir and tipranavir resistance for HIV-1 protease
    Wang, Yong
    Liu, Zhigang
    Brunzelle, Joseph S.
    Kovari, Iulia A.
    Dewdney, Tamaria G.
    Reiter, Samuel J.
    Kovari, Ladislau C.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 412 (04) : 737 - 742
  • [3] Resilience to resistance of HIV-1 protease inhibitors: Profile of darunavir
    Lefebvre, Eric
    Schiffer, Celia A.
    [J]. AIDS REVIEWS, 2008, 10 (03) : 131 - 142
  • [4] Mutations in HIV-1 protease associated with resistance to amprenavir contribute towards phenotypic resistance to lopinavir
    Parkin, NT
    Chappey, C
    Petropoulos, CJ
    [J]. ANTIVIRAL THERAPY, 2002, 7 : S29 - S29
  • [5] Atazanavir/darunavir/lopinavirDevelopment of drug resistance in HIV-1 infection: 9 case reports
    [J]. Reactions Weekly, 2017, 1673 (1) : 75 - 75
  • [6] HIV-1 Protease Codon 36 Polymorphisms and Differential Development of Resistance to Nelfinavir, Lopinavir, and Atazanavir in Different HIV-1 Subtypes
    Lisovsky, Irene
    Schader, Susan M.
    Martinez-Cajas, Jorge-Luis
    Oliveira, Maureen
    Moisi, Daniela
    Wainberg, Mark A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (07) : 2878 - 2885
  • [7] Energetic basis for drug resistance of HIV-1 protease mutants against amprenavir
    Parimal Kar
    Volker Knecht
    [J]. Journal of Computer-Aided Molecular Design, 2012, 26 : 215 - 232
  • [8] Energetic basis for drug resistance of HIV-1 protease mutants against amprenavir
    Kar, Parimal
    Knecht, Volker
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2012, 26 (02) : 215 - 232
  • [9] Loss of Protease Dimerization Inhibition Activity of Darunavir Is Associated with the Acquisition of Resistance to Darunavir by HIV-1
    Koh, Yasuhiro
    Aoki, Manabu
    Danish, Matthew L.
    Aoki-Ogata, Hiromi
    Amano, Masayuki
    Das, Debananda
    Shafer, Robert W.
    Ghosh, Arun K.
    Mitsuya, Hiroaki
    [J]. JOURNAL OF VIROLOGY, 2011, 85 (19) : 10079 - 10089
  • [10] Mechanism of drug resistance in HIV-1 protease subtype C in the presence of Atazanavir
    Sankaran, S. V.
    Krishnan, Sowmya R.
    Sayed, Yasien
    Gromiha, M. Michael
    [J]. CURRENT RESEARCH IN STRUCTURAL BIOLOGY, 2024, 7
12345